| 2001 | PECAM1 levels | GCST90470206 | 2.28 |
| 2002 | Sleep apnea (MTAG) | GCST90267362 | 2.27 |
| 2003 | ALB levels | GCST90018725 | 2.27 |
| 2004 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239 | ECGA000239 | 2.27 |
| 2005 | Varicose veins of lower extremity | circulatory system | UKBB00000895 | 2.27 |
| 2006 | PARK7 levels | GCST90470159 | 2.27 |
| 2007 | aseg rh intensity Thalamus-Proper | GCST90003782 | 2.27 |
| 2008 | PCDH1 levels | GCST90470170 | 2.27 |
| 2009 | IDP dMRI TBSS L2 Superior corona radiata L | GCST90004148 | 2.26 |
| 2010 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 2.26 |
| 2011 | IL17D levels | GCST90469560 | 2.26 |
| 2012 | CD55 levels | GCST90468637 | 2.26 |
| 2013 | ABHD14B/CCS ratio | GCST90313139 | 2.26 |
| 2014 | METAP1D/PLXNA4 ratio | GCST90315427 | 2.26 |
| 2015 | ADAMTS13 levels | GCST90468222 | 2.26 |
| 2016 | Cyst of kidney, acquired (PheCode 586.2) | GCST90476133 | 2.26 |
| 2017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78 | ECGA000078 | 2.25 |
| 2018 | DTI autoptx L3 atr l tract | GCST90385195 | 2.25 |
| 2019 | DTI autoptx FA slf l tract | GCST90385133 | 2.25 |
| 2020 | HS1BP3 levels | GCST90469477 | 2.25 |
| 2021 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424 | ECGA000424 | 2.24 |
| 2022 | CD69 levels | GCST90468643 | 2.24 |
| 2023 | IDP dMRI TBSS L2 External capsule L | GCST90004156 | 2.24 |
| 2024 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 2.24 |
| 2025 | ALB levels | GCST90497101 | 2.24 |
| 2026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108 | ECGA000108 | 2.24 |
| 2027 | HSDL2 levels | GCST90469485 | 2.24 |
| 2028 | Omega-6 fatty acids to total fatty acids percentage | GCST90502540 | 2.24 |
| 2029 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13) | GCST90320576 | 2.24 |
| 2030 | IDP T1 FAST ROIs R cerebellum VIIIb | GCST90002583 | 2.24 |
| 2031 | aparc-Desikan lh area pericalcarine | GCST90003093 | 2.23 |
| 2032 | Middle diffusion tensor imaging along the perivascular space index | GCST90455544 | 2.23 |
| 2033 | Frequency of light DIY in last 4 weeks | Physical activity | UKBB00000264 | 2.23 |
| 2034 | Pain type(s) experienced in last month - Headache | Pain | UKBB00000627 | 2.23 |
| 2035 | NID1/NID2 ratio | GCST90315541 | 2.23 |
| 2036 | CLMP/GFRA1 ratio | GCST90314133 | 2.23 |
| 2037 | IDP dMRI ProbtrackX ISOVF ar r | GCST90004526 | 2.23 |
| 2038 | CCL22/PDGFB ratio | GCST90313692 | 2.23 |
| 2039 | Diacylglycerol_36:4_[M+H-H2O]1+ levels | GCST90060188 | 2.23 |
| 2040 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21 | ECGU000021 | 2.22 |
| 2041 | Operation year/age first occurred | Operations | UKBB00000570 | 2.22 |
| 2042 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89 | ECGU000089 | 2.22 |
| 2043 | Total testosterone levels | GCST90012114 | 2.22 |
| 2044 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 2.22 |
| 2045 | PDGFC levels | GCST90470190 | 2.21 |
| 2046 | Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000236 | 2.21 |
| 2047 | Pulmonary fibrosis | GCST90018688 | 2.21 |
| 2048 | ALCAM/CDH5 ratio | GCST90313234 | 2.21 |
| 2049 | Hypopotassemia (PheCode 276.14) | GCST90475755 | 2.21 |
| 2050 | Left-hemisphere salience/ventral attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302711 | 2.21 |
| 2051 | IDP dMRI ProbtrackX FA str r | GCST90003949 | 2.21 |
| 2052 | Paroxysmal supraventricular tachycardia (PheCode 427.11) | GCST90475964 | 2.21 |
| 2053 | Sphingomyelin_40:2_[M+H]1+ levels | GCST90060352 | 2.21 |
| 2054 | C5 levels | GCST90468500 | 2.21 |
| 2055 | PODXL levels | GCST90470280 | 2.20 |
| 2056 | Hypertension (confirmatory factor analysis Factor 12) | GCST90309346 | 2.20 |
| 2057 | Cholesteryl ester_18:1_[M+NH4]1+ levels | GCST90060221 | 2.20 |
| 2058 | CPXM1/MDK ratio | GCST90314221 | 2.20 |
| 2059 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 2.20 |
| 2060 | LRP11/NECTIN2 ratio | GCST90315329 | 2.19 |
| 2061 | EPCAM levels | GCST90469126 | 2.19 |
| 2062 | DAPP1 levels | GCST90468946 | 2.19 |
| 2063 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 2.19 |
| 2064 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T109 | ECGA000109 | 2.19 |
| 2065 | aparc-a2009s lh area G+S-subcentral | GCST90003300 | 2.19 |
| 2066 | Left-hemisphere dorsal attention network to right-hemisphere visual network white-matter structural connectivity | GCST90302694 | 2.19 |
| 2067 | Bone marrow fat fraction of lumbar vertebra 1 | GCST90652386 | 2.19 |
| 2068 | Benign neoplasm of colon, rectum, anus and anal canal | FING00000155 | 2.19 |
| 2069 | SRPK2 levels | GCST90470743 | 2.19 |
| 2070 | Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302669 | 2.18 |
| 2071 | Phospholipids in large HDL (UKB data field 23560) | GCST90269657 | 2.18 |
| 2072 | CTF1 levels | GCST90468901 | 2.18 |
| 2073 | Other headache syndromes | FING00001055 | 2.18 |
| 2074 | Arabitol/xylitol levels | GCST90200011 | 2.18 |
| 2075 | PLPBP levels | GCST90470260 | 2.18 |
| 2076 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78 | ECGU000078 | 2.18 |
| 2077 | CLEC1B/TXNDC5 ratio | GCST90314105 | 2.18 |
| 2078 | Left ventricular end systole inferior wall thickness | GCST90278509 | 2.18 |
| 2079 | Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels | GCST90060254 | 2.18 |
| 2080 | High blood pressure / hypertension | GCST90475214 | 2.18 |
| 2081 | CCL11 levels | GCST90274764 | 2.18 |
| 2082 | PDCD1LG2 levels | GCST90470180 | 2.18 |
| 2083 | IDP dMRI TBSS MD Posterior corona radiata R | GCST90004053 | 2.17 |
| 2084 | 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels | GCST90200685 | 2.17 |
| 2085 | Heart failure and bmi 25plus | FING00000603 | 2.17 |
| 2086 | BA-exvivo lh volume BA2 | GCST90002836 | 2.17 |
| 2087 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 2.17 |
| 2088 | Hip minimal joint space width | GCST90281365 | 2.17 |
| 2089 | NUMB levels | GCST90470108 | 2.17 |
| 2090 | Testosterone | Blood biochemistry | UKBB00000816 | 2.17 |
| 2091 | PRKAR2A levels | GCST90470327 | 2.16 |
| 2092 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103) | GCST90320922 | 2.16 |
| 2093 | Weight-to-muscle ratio | GCST90267359 | 2.16 |
| 2094 | low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed) | GCST90475420 | 2.16 |
| 2095 | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels | GCST90199853 | 2.16 |
| 2096 | RSPO1 levels | GCST90470503 | 2.16 |
| 2097 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 2.16 |
| 2098 | IL31RA levels | GCST90469589 | 2.16 |
| 2099 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382 | ECGU000382 | 2.16 |
| 2100 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T47 | ECGU000047 | 2.15 |
| 2101 | wg rh intensity-contrast middletemporal | GCST90003841 | 2.15 |
| 2102 | FOLH1 levels | GCST90241272 | 2.15 |
| 2103 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475354 | 2.15 |
| 2104 | Congestive heart failure | GCST90475200 | 2.15 |
| 2105 | CLMP/TNFRSF19 ratio | GCST90314136 | 2.15 |
| 2106 | ING1 levels | GCST90469613 | 2.15 |
| 2107 | IDP dMRI TBSS ISOVF Sagittal stratum L | GCST90004508 | 2.15 |
| 2108 | Free cholesterol in very large VLDL | GCST90500581 | 2.14 |
| 2109 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 2.14 |
| 2110 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T299 | ECGU000299 | 2.14 |
| 2111 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 2.14 |
| 2112 | IDP dMRI ProbtrackX FA atr l | GCST90003927 | 2.14 |
| 2113 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41 | ECGA000041 | 2.14 |
| 2114 | IDP dMRI ProbtrackX MD cst r | GCST90004228 | 2.14 |
| 2115 | Bilirubin (E,Z or Z,E) levels | GCST90243750 | 2.14 |
| 2116 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233 | ECGA000233 | 2.13 |
| 2117 | aseg lh intensity Thalamus-Proper | GCST90003768 | 2.13 |
| 2118 | Lysoalkylphosphatidylcholine (O-22:1) levels | GCST90024196 | 2.13 |
| 2119 | MPIG6B levels | GCST90469935 | 2.12 |
| 2120 | aparc-a2009s rh volume S-calcarine | GCST90003042 | 2.12 |
| 2121 | CCL19 levels | GCST90274765 | 2.12 |
| 2122 | EIF2AK2 levels | GCST90469091 | 2.12 |
| 2123 | Eustachian tube disorders (PheCode 381.2) | GCST90475904 | 2.12 |
| 2124 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320901 | 2.12 |
| 2125 | IGF2R/RNASET2 ratio | GCST90315132 | 2.12 |
| 2126 | ALB levels | UKBB00000019 | 2.12 |
| 2127 | Parental longevity (both parents in top 10%) | GCST006698 | 2.12 |
| 2128 | X-16087 levels | GCST90200537 | 2.12 |
| 2129 | SLC9A3R2 levels | GCST90470666 | 2.11 |
| 2130 | ADGRE2/CD58 ratio | GCST90313175 | 2.11 |
| 2131 | CXCL12 levels | GCST90468925 | 2.11 |
| 2132 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T105 | ECGA000105 | 2.11 |
| 2133 | NIT2 levels | GCST90470051 | 2.11 |
| 2134 | MCFD2 levels | GCST90469873 | 2.11 |
| 2135 | aparc-a2009s lh area S-postcentral | GCST90003363 | 2.11 |
| 2136 | Prescriptions - selective beta1 antagonist|beta blocker | UKBB00000699 | 2.10 |
| 2137 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T302 | ECGU000302 | 2.10 |
| 2138 | IGLL1 levels | GCST90241473 | 2.10 |
| 2139 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 2.10 |
| 2140 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381 | ECGU000381 | 2.10 |
| 2141 | Familial combined hyperlipidemia defined by Dutch criteria | GCST90104005 | 2.10 |
| 2142 | Pustulosis palmaris et plantaris | FING00001233 | 2.10 |
| 2143 | JAM2/TGFBR2 ratio | GCST90315238 | 2.10 |
| 2144 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T304 | ECGU000304 | 2.10 |
| 2145 | SPART levels | GCST90470719 | 2.10 |
| 2146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16 | ECGU000016 | 2.09 |
| 2147 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19 | ECGU000019 | 2.09 |
| 2148 | TPD52L2 levels | GCST90470942 | 2.09 |
| 2149 | Citrate levels | GCST90243442 | 2.09 |
| 2150 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49 | ECGU000049 | 2.09 |
| 2151 | NTRK2 levels | GCST90470097 | 2.09 |
| 2152 | WASF1 levels | GCST90471067 | 2.09 |
| 2153 | CLU levels | GCST90468793 | 2.09 |
| 2154 | Early age-related macular degeneration | GCST010723 | 2.08 |
| 2155 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T316 | ECGA000316 | 2.08 |
| 2156 | ADM/CLMP ratio | GCST90313197 | 2.08 |
| 2157 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 2.08 |
| 2158 | N-acetylalanine levels | GCST90200303 | 2.08 |
| 2159 | Recent feelings or nervousness or anxiety | Anxiety | UKBB00000741 | 2.08 |
| 2160 | CLSTN2/MATN2 ratio | GCST90314143 | 2.08 |
| 2161 | GRAP2/PTPN6 ratio | GCST90314986 | 2.07 |
| 2162 | C1QTNF1/COL4A1 ratio | GCST90313552 | 2.07 |
| 2163 | MINK1 levels | GCST90469909 | 2.07 |
| 2164 | CRYZL1 levels | GCST90468878 | 2.07 |
| 2165 | ICA1 levels | GCST90469497 | 2.07 |
| 2166 | rfMRI connectivity ICA-features 3 | GCST90006341 | 2.07 |
| 2167 | Pulse wave Arterial Stiffness index | Arterial stiffness | UKBB00000724 | 2.07 |
| 2168 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 2.07 |
| 2169 | Ulcerative colitis | GCST90476067 | 2.07 |
| 2170 | YWHAQ levels | GCST90471092 | 2.06 |
| 2171 | Heart rate variability (corrected standard deviation of normal-to-normal intervals) | GCST90281266 | 2.06 |
| 2172 | Nasal polyps (PheCode 471) | GCST90476019 | 2.05 |
| 2173 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393 | ECGA000393 | 2.05 |
| 2174 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 2.05 |
| 2175 | NT5C1A levels | GCST90470090 | 2.05 |
| 2176 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476347 | 2.05 |
| 2177 | FABP6 levels | GCST90469178 | 2.05 |
| 2178 | EGFR/MEGF9 ratio | GCST90314614 | 2.05 |
| 2179 | Waist-hip ratio | GCST90278649 | 2.05 |
| 2180 | Conductive hearing loss (PheCode 389.2) | GCST90475912 | 2.04 |
| 2181 | ITPA levels | GCST90469654 | 2.04 |
| 2182 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 2.04 |
| 2183 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502644 | 2.04 |
| 2184 | SNAP29 levels | GCST90470692 | 2.03 |
| 2185 | Right ventricular end systolic volume | GCST90268118 | 2.03 |
| 2186 | CLEC1B/VTA1 ratio | GCST90314107 | 2.03 |
| 2187 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94 | ECGU000094 | 2.03 |
| 2188 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 2.03 |
| 2189 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49 | ECGA000049 | 2.03 |
| 2190 | Triacylglycerol_46:5_[M+NH4]1+ levels | GCST90060356 | 2.03 |
| 2191 | CELA3A/CTRB1 ratio | GCST90314011 | 2.03 |
| 2192 | Maximum digits remembered correctly | Numeric memory | UKBB00000430 | 2.03 |
| 2193 | Sphingomyelin_36:1_[M+H]1+ levels | GCST90060266 | 2.03 |
| 2194 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395 | ECGA000395 | 2.02 |
| 2195 | Retinal venular tortuosity | GCST90270399 | 2.02 |
| 2196 | SOST levels | GCST90470711 | 2.02 |
| 2197 | ICD10 N80: Endometriosis | GCST90454213 | 2.02 |
| 2198 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361 | ECGU000361 | 2.01 |
| 2199 | aparc-DKTatlas rh volume parsopercularis | GCST90002909 | 2.01 |
| 2200 | Iron deficiency anaemia | FING00000699 | 2.01 |
| 2201 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 2.01 |
| 2202 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 2.01 |
| 2203 | CCL21 levels | GCST90468573 | 2.01 |
| 2204 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000437 | 2.01 |
| 2205 | CILP levels | GCST90468754 | 2.01 |
| 2206 | DTD1 levels | GCST90469045 | 2.01 |
| 2207 | C1QTNF5 levels | GCST90468489 | 2.01 |
| 2208 | Autorefraction - 3mm asymmetry angle (left) | Eyesight | UKBB00000060 | 2.01 |
| 2209 | TNFRSF8/TNFRSF9 ratio | GCST90315940 | 2.01 |
| 2210 | DTI TBSS L2 Sagittal stratum R | GCST90384506 | 2.01 |
| 2211 | PTPRM levels | GCST90470384 | 2.01 |
| 2212 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502181 | 2.00 |
| 2213 | CD177 levels | GCST90468603 | 2.00 |
| 2214 | Melanocytic naevi of trunk | FING00000800 | 2.00 |
| 2215 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502567 | 2.00 |
| 2216 | Migraine | GCST90468142 | 2.00 |
| 2217 | Free cholesterol in very small VLDL | GCST90500777 | 2.00 |
| 2218 | Parental longevity (combined parental attained age, Martingale residuals) | GCST006697 | 2.00 |
| 2219 | Phospholipids in large VLDL | GCST90498243 | 2.00 |
| 2220 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42 | ECGA000042 | 2.00 |
| 2221 | Diacylglycerol_36:3_[M+H-H2O]1+ levels | GCST90060189 | 2.00 |
| 2222 | AXL/MSR1 ratio | GCST90313422 | 2.00 |
| 2223 | Autorefraction - 6mm strong meridian angle (left) | Eyesight | UKBB00000077 | 2.00 |
| 2224 | CLEC14A levels | GCST90468766 | 2.00 |
| 2225 | Subjective well-being | GCST90104897 | 1.99 |
| 2226 | MAP2K6 levels | GCST90469852 | 1.99 |
| 2227 | FAM172A levels | GCST90469184 | 1.99 |
| 2228 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 1.99 |
| 2229 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394 | ECGA000394 | 1.99 |
| 2230 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 1.99 |
| 2231 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000434 | 1.99 |
| 2232 | Right hippocampal volume (tail) | GCST90267973 | 1.98 |
| 2233 | Peripheral vascular disease | GCST90086134 | 1.98 |
| 2234 | Sphingomyelin_40:3_[M+H]1+ levels | GCST90060348 | 1.98 |
| 2235 | AGT levels | GCST90468257 | 1.98 |
| 2236 | IL3RA levels | GCST90469596 | 1.98 |
| 2237 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T65 | ECGU000065 | 1.98 |
| 2238 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T360 | ECGU000360 | 1.98 |
| 2239 | Non-cancer illness code, self-reported - glaucoma | Medical conditions | UKBB00000511 | 1.98 |
| 2240 | IDP dMRI ProbtrackX L2 slf l | GCST90004294 | 1.98 |
| 2241 | Mean arterial pressure (BMI adjusted) | GCST90335169 | 1.98 |
| 2242 | Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264329 | 1.98 |
| 2243 | Heterophoria | FING00000620 | 1.98 |
| 2244 | MAPK9 levels | GCST90469857 | 1.98 |
| 2245 | SUMF2 levels | GCST90470784 | 1.97 |
| 2246 | FABP2 levels | GCST90469174 | 1.97 |
| 2247 | Psoriasis vulgaris | GCST90018687 | 1.97 |
| 2248 | CLEC10A levels | GCST90468763 | 1.97 |
| 2249 | Diaphragmatic hernia | Hernia | UKBB00000172 | 1.97 |
| 2250 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21 | ECGA000021 | 1.97 |
| 2251 | IDP dMRI ProbtrackX ICVF ar r | GCST90004376 | 1.97 |
| 2252 | FAM3B/FGF19 ratio | GCST90314776 | 1.97 |
| 2253 | 4-acetamidobutanoate levels | GCST90243440 | 1.97 |
| 2254 | PLA2G15/PRCP ratio | GCST90315661 | 1.97 |
| 2255 | LTBP2/PDGFRA ratio | GCST90315338 | 1.97 |
| 2256 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429 | ECGA000429 | 1.97 |
| 2257 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000439 | 1.96 |
| 2258 | MCAM/NTRK3 ratio | GCST90315409 | 1.96 |
| 2259 | DTI TBSS L3 Retrolenticular part of internal capsule R | GCST90384544 | 1.96 |
| 2260 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T317 | ECGA000317 | 1.96 |
| 2261 | LILRB4 levels | GCST90469778 | 1.96 |
| 2262 | aparc-DKTatlas lh area lateraloccipital | GCST90003243 | 1.96 |
| 2263 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320947 | 1.96 |
| 2264 | wg lh intensity-contrast precuneus | GCST90003816 | 1.96 |
| 2265 | ACVRL1/TNFRSF10B ratio | GCST90313158 | 1.95 |
| 2266 | ITGB1BP2/STAT5B ratio | GCST90315220 | 1.95 |
| 2267 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T102 | ECGA000102 | 1.95 |
| 2268 | PLA2G10 levels | GCST90470244 | 1.95 |
| 2269 | Benign lipomatous neoplasm | FING00000146 | 1.95 |
| 2270 | Total protein levels | UKBB00000826 | 1.95 |
| 2271 | Asphyxia and hypoxemia (PheCode 1013) | GCST90475559 | 1.95 |
| 2272 | DTI TBSS L3 Uncinate fasciculus R | GCST90384568 | 1.95 |
| 2273 | Fracture of radius and ulna (PheCode 803.2) | GCST90476280 | 1.95 |
| 2274 | Gout | FING00000587 | 1.95 |
| 2275 | Physical decline (log-difference score) | GCST90565847 | 1.95 |
| 2276 | Free cholesterol in large VLDL | GCST90498181 | 1.95 |
| 2277 | Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels | GCST90060147 | 1.95 |
| 2278 | DNAJB14 levels | GCST90240952 | 1.95 |
| 2279 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48) | GCST90320611 | 1.95 |
| 2280 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000433 | 1.94 |
| 2281 | CREG1/SMPDL3A ratio | GCST90314252 | 1.94 |
| 2282 | Left ventricular end systole inferolateral wall thickness | GCST90278510 | 1.94 |
| 2283 | Alanine transaminase (ALT, maximum, inv-norm transformed) | GCST90475109 | 1.94 |
| 2284 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112 | ECGU000112 | 1.94 |
| 2285 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 1.94 |
| 2286 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T315 | ECGA000315 | 1.94 |
| 2287 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels | GCST90200075 | 1.94 |
| 2288 | PGR levels | GCST90470223 | 1.94 |
| 2289 | PSG1 levels | GCST90470353 | 1.93 |
| 2290 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 1.93 |
| 2291 | CALCOCO2 levels | GCST90468531 | 1.93 |
| 2292 | FURIN/IGSF3 ratio | GCST90314885 | 1.93 |
| 2293 | DDR1 levels | GCST90468970 | 1.93 |
| 2294 | 1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels | GCST90200057 | 1.93 |
| 2295 | CXCL5 levels | GCST90000461 | 1.93 |
| 2296 | X-13548 levels | GCST90243821 | 1.93 |
| 2297 | PTX3 levels | GCST90470392 | 1.93 |
| 2298 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000438 | 1.93 |
| 2299 | C2/SSC5D ratio | GCST90313555 | 1.93 |
| 2300 | S100A4 levels | GCST90470518 | 1.92 |
| 2301 | Right molecular layer hippocampal volume (body) | GCST90267975 | 1.92 |
| 2302 | PDCD1/TNFRSF8 ratio | GCST90315610 | 1.92 |
| 2303 | C1QTNF1 levels | GCST90468488 | 1.92 |
| 2304 | SERPINB8 levels | GCST90470592 | 1.92 |
| 2305 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000440 | 1.92 |
| 2306 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425 | ECGA000425 | 1.92 |
| 2307 | Ovarian cancer-related tumor marker CA 125 levels | GCST90012078 | 1.92 |
| 2308 | Unspecified/other endometriosis | FING00001404 | 1.92 |
| 2309 | IDP dMRI TBSS L3 Posterior corona radiata R | GCST90004197 | 1.92 |
| 2310 | PEBP1 levels | GCST90470205 | 1.91 |
| 2311 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43 | ECGA000043 | 1.91 |
| 2312 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362 | ECGU000362 | 1.91 |
| 2313 | NUDC levels | GCST90470102 | 1.91 |
| 2314 | Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2) | GCST90475770 | 1.91 |
| 2315 | Multi-trait sex score | GCST90270118 | 1.91 |
| 2316 | Linoleic acid to total fatty acids percentage | GCST90502333 | 1.91 |
| 2317 | Triacylglycerol (50:0) [NL-18:0] levels | GCST90025151 | 1.91 |
| 2318 | Spatial QRS-T angle | GCST90246320 | 1.91 |
| 2319 | CSF1/LTBR ratio | GCST90314287 | 1.91 |
| 2320 | IDP dMRI ProbtrackX ICVF unc r | GCST90004401 | 1.91 |
| 2321 | Essential hypertension | circulatory system | UKBB00000209 | 1.91 |
| 2322 | Hypertension | circulatory system | UKBB00000334 | 1.91 |
| 2323 | Weight change compared with 1 year ago | General health | UKBB00000911 | 1.91 |
| 2324 | LAT2/SERPINB1 ratio | GCST90315279 | 1.90 |
| 2325 | SPON1 levels | GCST90470731 | 1.90 |
| 2326 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 1.90 |
| 2327 | MRAP levels | GCST90089910 | 1.90 |
| 2328 | SYAP1 levels | GCST90470792 | 1.90 |
| 2329 | Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3) | GCST90476115 | 1.90 |
| 2330 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 1.90 |
| 2331 | MEPE/SOST ratio | GCST90315420 | 1.90 |
| 2332 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T63 | ECGU000063 | 1.90 |
| 2333 | ASGR1/DCBLD2 ratio | GCST90313364 | 1.90 |
| 2334 | aparc-a2009s rh area G+S-occipital-inf | GCST90003372 | 1.90 |
| 2335 | LSP1/NADK ratio | GCST90315331 | 1.90 |
| 2336 | T1 FreeSurfer BA rh BA3b exvivo area | GCST90385550 | 1.90 |
| 2337 | C2/LILRB4 ratio | GCST90313554 | 1.89 |
| 2338 | Benign neoplasm: Rectum, anus and anal canal | FING00000197 | 1.89 |
| 2339 | Diastolic blood pressure | GCST90472778 | 1.89 |
| 2340 | Abnormalities of forces of labour | FING00000003 | 1.89 |
| 2341 | LTBR/TNFRSF14 ratio | GCST90315340 | 1.89 |
| 2342 | Osteoporosis | FING00000914 | 1.89 |
| 2343 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T315 | ECGU000315 | 1.89 |
| 2344 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320681 | 1.88 |
| 2345 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 1.88 |
| 2346 | ENO2/SULT1A1 ratio | GCST90314669 | 1.88 |
| 2347 | Triglycerides in very small VLDL | GCST90500873 | 1.88 |
| 2348 | DTI TBSS L3 Superior longitudinal fasciculus R | GCST90384564 | 1.88 |
| 2349 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | GCST90475348 | 1.88 |
| 2350 | Treatment/medication code - perindopril | Medications | UKBB00000854 | 1.87 |
| 2351 | Phenylacetylcarnitine levels | GCST90199993 | 1.87 |
| 2352 | aseg global volume BrainSeg | GCST90002590 | 1.87 |
| 2353 | CCN3/COL6A3 ratio | GCST90313720 | 1.87 |
| 2354 | SOD1 levels | GCST90470704 | 1.87 |
| 2355 | Total Alkenylphosphatidylcholine levels | GCST90025835 | 1.87 |
| 2356 | BA-exvivo rh volume BA45 | GCST90002857 | 1.87 |
| 2357 | X-11786--methylcysteine levels | GCST90243654 | 1.87 |
| 2358 | EIF4G1 levels | GCST90469097 | 1.87 |
| 2359 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359 | ECGU000359 | 1.87 |
| 2360 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 1.87 |
| 2361 | STROKE | FING00001336 | 1.87 |
| 2362 | Insomnia (PheCode 327.4) | GCST90475826 | 1.87 |
| 2363 | CA2/PSMG3 ratio | GCST90313581 | 1.86 |
| 2364 | SFTPA1 levels | GCST90470612 | 1.86 |
| 2365 | MIF/PARK7 ratio | GCST90315447 | 1.86 |
| 2366 | CRNN levels | GCST90277890 | 1.85 |
| 2367 | Hypertension, essential | FING00000638 | 1.85 |
| 2368 | DARS1/EIF4B ratio | GCST90314403 | 1.85 |
| 2369 | IDP dMRI ProbtrackX L3 slf l | GCST90004321 | 1.85 |
| 2370 | wg rh intensity-contrast inferiorparietal | GCST90003834 | 1.85 |
| 2371 | rfMRI amplitudes (ICA25 node 12) | GCST90004579 | 1.85 |
| 2372 | ITPR1 levels | GCST90469655 | 1.85 |
| 2373 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000435 | 1.85 |
| 2374 | NID2 levels | GCST90470048 | 1.85 |
| 2375 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000436 | 1.84 |
| 2376 | NFU1 levels | GCST90470040 | 1.84 |
| 2377 | aparc-a2009s lh area S-calcarine | GCST90003340 | 1.84 |
| 2378 | Forced expiratory volume in 1-second (FEV1), predicted percentage | Spirometry | UKBB00000253 | 1.84 |
| 2379 | Cholesterol in Medium LDL | GCST90498707 | 1.84 |
| 2380 | Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302699 | 1.84 |
| 2381 | Other benign neoplasms of skin | FING00000971 | 1.84 |
| 2382 | CD164 levels | GCST90468602 | 1.83 |
| 2383 | BA-exvivo rh area MT | GCST90003232 | 1.83 |
| 2384 | P4HB/PPP1R12A ratio | GCST90315591 | 1.83 |
| 2385 | GPI levels | GCST90469391 | 1.83 |
| 2386 | Left-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302736 | 1.83 |
| 2387 | LTA4H levels | GCST90469812 | 1.83 |
| 2388 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426 | ECGA000426 | 1.83 |
| 2389 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38 | ECGA000038 | 1.83 |
| 2390 | Sphingomyelin_42:2_[M+OAc]1- levels | GCST90060507 | 1.83 |
| 2391 | aparc-a2009s rh volume G-precentral | GCST90003027 | 1.83 |
| 2392 | FGF19/SCG2 ratio | GCST90314809 | 1.82 |
| 2393 | Glaucoma (PheCode 365) | GCST008373 | 1.82 |
| 2394 | Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302804 | 1.82 |
| 2395 | Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485) | GCST90269582 | 1.82 |
| 2396 | DNAJB14 levels | GCST90469011 | 1.82 |
| 2397 | Colon cancer | GCST90011811 | 1.82 |
| 2398 | Left-hemisphere control network to caudate white-matter structural connectivity | GCST90302753 | 1.82 |
| 2399 | Fractured bone site(s) - Other bones | Medical conditions | UKBB00000256 | 1.82 |
| 2400 | AGRN levels | GCST90468255 | 1.82 |
| 2401 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 1.82 |
| 2402 | X-12063 levels | GCST90243687 | 1.82 |
| 2403 | FOXO3 levels | GCST90469266 | 1.82 |
| 2404 | CASP7 levels | GCST90468547 | 1.82 |
| 2405 | Frontal QRS-T angle | GCST90246321 | 1.82 |
| 2406 | IDP dMRI TBSS L3 Cingulum hippocampus R | GCST90004207 | 1.81 |
| 2407 | DSG2 levels | GCST90469042 | 1.81 |
| 2408 | Average diameter for HDL particles | GCST90497454 | 1.81 |
| 2409 | Dorsopathies | FING00000473 | 1.81 |
| 2410 | IDP dMRI TBSS L3 Superior longitudinal fasciculus L | GCST90004212 | 1.81 |
| 2411 | Cancer (standard GWA) | GCST90267270 | 1.81 |
| 2412 | ST13 levels | GCST90470751 | 1.81 |
| 2413 | DOK1 levels | GCST90469028 | 1.81 |
| 2414 | HPGDS/ITGAV ratio | GCST90315080 | 1.81 |
| 2415 | Light smokers, at least 100 smokes in lifetime | Smoking | UKBB00000407 | 1.81 |
| 2416 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458) | GCST90269555 | 1.80 |
| 2417 | Linoleic acid levels | GCST90498309 | 1.80 |
| 2418 | Ascending aorta distensibility | GCST90267385 | 1.80 |
| 2419 | LRP11/ROR1 ratio | GCST90315330 | 1.80 |
| 2420 | RWDD1 levels | GCST90470510 | 1.80 |
| 2421 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33) | GCST90320596 | 1.80 |
| 2422 | FHIT/PMVK ratio | GCST90314822 | 1.80 |
| 2423 | Central pulse pressure | GCST90267387 | 1.80 |
| 2424 | TMSB10/ZBTB16 ratio | GCST90315926 | 1.80 |
| 2425 | CXCL12/TIMP3 ratio | GCST90314338 | 1.80 |
| 2426 | triglyceride (maximum, inv-norm transformed) | GCST90476429 | 1.80 |
| 2427 | COL1A1 levels | GCST90468813 | 1.80 |
| 2428 | APOA4 levels | GCST90468333 | 1.80 |
| 2429 | Breast cancer | neoplasms | UKBB00000109 | 1.79 |
| 2430 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T308 | ECGA000308 | 1.79 |
| 2431 | PDLIM7/SRC ratio | GCST90315639 | 1.79 |
| 2432 | GMFG levels | GCST90469366 | 1.79 |
| 2433 | CD20 on IgD- CD38- B cell | GCST90001755 | 1.79 |
| 2434 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500 | ECGA000500 | 1.79 |
| 2435 | CCL16 levels | GCST90179243 | 1.78 |
| 2436 | FCRL2/LY9 ratio | GCST90314799 | 1.78 |
| 2437 | aseg rh volume choroid-plexus | GCST90002646 | 1.78 |
| 2438 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499804 | 1.78 |
| 2439 | Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary Operations | UKBB00000579 | 1.78 |
| 2440 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185 | ECGU000185 | 1.78 |
| 2441 | T1 FreeSurfer a2009s lh S temporal sup area | GCST90384740 | 1.78 |
| 2442 | wg rh intensity-contrast inferiortemporal | GCST90003835 | 1.78 |
| 2443 | IL6ST/MARCO ratio | GCST90315167 | 1.78 |
| 2444 | wg rh intensity-contrast supramarginal | GCST90003857 | 1.78 |
| 2445 | MYOC levels | GCST90422825 | 1.78 |
| 2446 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T319 | ECGA000319 | 1.77 |
| 2447 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 1.77 |
| 2448 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T48 | ECGU000048 | 1.77 |
| 2449 | PPP1R12A levels | GCST90470300 | 1.77 |
| 2450 | CTSL levels | GCST90468914 | 1.77 |
| 2451 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428 | ECGA000428 | 1.76 |
| 2452 | Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney disease | GCST90264796 | 1.76 |
| 2453 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 1.76 |
| 2454 | Hypertensive Heart Disease | FING00000639 | 1.76 |
| 2455 | CST3/EFEMP1 ratio | GCST90314292 | 1.76 |
| 2456 | CHCHD10 levels | GCST90468738 | 1.76 |
| 2457 | Sphingomyelin_41:2_[M+H]1+ levels | GCST90060383 | 1.76 |
| 2458 | Margaroylcarnitine (C17) levels | GCST90199929 | 1.76 |
| 2459 | DTI TBSS MD Fornix | GCST90384577 | 1.76 |
| 2460 | Phospholipids in very large VLDL | GCST90500647 | 1.76 |
| 2461 | Bone marrow fat fraction of lumbar vertebra 4 | GCST90652389 | 1.76 |
| 2462 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484 | ECGU000484 | 1.76 |
| 2463 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 1.75 |
| 2464 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 1.75 |
| 2465 | IDP dMRI TBSS L2 External capsule R | GCST90004155 | 1.75 |
| 2466 | WASHC3 levels | GCST90471069 | 1.75 |
| 2467 | Corneal edema (PheCode 364.2) | GCST90475862 | 1.75 |
| 2468 | aparc-DKTatlas lh thickness lateraloccipital | GCST90003549 | 1.75 |
| 2469 | Fibroblastic disorders | FING00000542 | 1.75 |
| 2470 | DKK1/VTA1 ratio | GCST90314485 | 1.75 |
| 2471 | PTP4A3 levels | GCST90470375 | 1.75 |
| 2472 | SRC/TBL1X ratio | GCST90315884 | 1.75 |
| 2473 | Anemia of chronic disease (PheCode 285.2) | GCST90475790 | 1.75 |
| 2474 | Diverticulitis (PheCode 562.2) | GCST90476077 | 1.75 |
| 2475 | 3-amino-2-piperidone levels | GCST90200188 | 1.75 |
| 2476 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 1.75 |
| 2477 | Testicular hypofunction (PheCode 257.1) | GCST90475697 | 1.75 |
| 2478 | Trunk fat-free mass | Impedance measures | UKBB00000865 | 1.75 |
| 2479 | aparc-pial rh area pericalcarine | GCST90003194 | 1.75 |
| 2480 | VLDL cholesterol levels | GCST90500189 | 1.74 |
| 2481 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430 | ECGA000430 | 1.74 |
| 2482 | Trunk predicted mass | Impedance measures | UKBB00000866 | 1.74 |
| 2483 | Male-pattern baldness | GCST006661 | 1.74 |
| 2484 | Hypertensive heart disease (PheCode 401.21) | GCST90475925 | 1.74 |
| 2485 | CIAPIN1/SPARC ratio | GCST90314069 | 1.74 |
| 2486 | IL22 levels | GCST90088066 | 1.74 |
| 2487 | Varicose veins of lower extremity (PheCode 454.1) | GCST90476013 | 1.73 |
| 2488 | Other peripheral nerve disorders | neurological | UKBB00000618 | 1.73 |
| 2489 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 1.73 |
| 2490 | Hyperglyceridemia (PheCode 272.12) | GCST90475724 | 1.73 |
| 2491 | Normotensive glaucoma | FING00000892 | 1.73 |
| 2492 | BA-exvivo rh volume MT | GCST90002860 | 1.73 |
| 2493 | Urine glucosaminate levels in chronic kidney disease | GCST90265179 | 1.73 |
| 2494 | 1-linoleoyl-GPI (18:2) levels | GCST90199821 | 1.73 |
| 2495 | ICD10 O26.6: Liver disorders in pregnancy, childbirth and puerperium | GCST90454237 | 1.73 |
| 2496 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T316 | ECGU000316 | 1.73 |
| 2497 | DAB2 levels | GCST90468942 | 1.72 |
| 2498 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 1.72 |
| 2499 | IDS/SMPDL3A ratio | GCST90315126 | 1.72 |
| 2500 | IDP dMRI TBSS MD Superior corona radiata R | GCST90004051 | 1.72 |
| 2501 | DTI TBSS FA Splenium of corpus callosum | GCST90384384 | 1.72 |
| 2502 | Acute renal failure | FING00000030 | 1.72 |
| 2503 | CCL13/CCL2 ratio | GCST90313675 | 1.72 |
| 2504 | Volume of left basal nucleus | GCST90474877 | 1.72 |
| 2505 | Myocardial fractal dimension (slice 7) | GCST90000293 | 1.72 |
| 2506 | APPL2 levels | GCST90468343 | 1.72 |
| 2507 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427 | ECGA000427 | 1.72 |
| 2508 | MPI levels | GCST90469936 | 1.72 |
| 2509 | Diastolic blood pressure | GCST90472779 | 1.72 |
| 2510 | HLA-DRA levels | GCST90469458 | 1.71 |
| 2511 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 1.71 |
| 2512 | Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481) | GCST90269578 | 1.71 |
| 2513 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390 | ECGA000390 | 1.71 |
| 2514 | CD200 levels | GCST90468606 | 1.71 |
| 2515 | MINDY1 levels | GCST90469908 | 1.71 |
| 2516 | Coxarthrosis, primary, with hip surgery | FING00000364 | 1.71 |
| 2517 | SMOC2 levels | GCST90470683 | 1.71 |
| 2518 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475350 | 1.71 |
| 2519 | Normal-pressure hydrocephalus | FING00000891 | 1.70 |
| 2520 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T110 | ECGA000110 | 1.70 |
| 2521 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108 | ECGU000108 | 1.70 |
| 2522 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T236 | ECGU000236 | 1.70 |
| 2523 | IL12B levels | GCST90274798 | 1.70 |
| 2524 | Facial ageing | Sun exposure | UKBB00000233 | 1.70 |
| 2525 | ADGRE2/B4GALT1 ratio | GCST90313174 | 1.70 |
| 2526 | PRDX5 levels | GCST90470318 | 1.70 |
| 2527 | Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302763 | 1.70 |
| 2528 | Octadecenedioylcarnitine (C18:1-DC) levels | GCST90199970 | 1.70 |
| 2529 | ICD10 O20: Haemorrhage in early pregnancy | GCST90454235 | 1.70 |
| 2530 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391 | ECGA000391 | 1.70 |
| 2531 | CD276 levels | GCST90468614 | 1.70 |
| 2532 | Otosclerosis | GCST90129575 | 1.70 |
| 2533 | PLXNA4/SKAP2 ratio | GCST90315685 | 1.70 |
| 2534 | ANXA3 levels | GCST90468318 | 1.69 |
| 2535 | CD93 levels | GCST90468656 | 1.69 |
| 2536 | DTI TBSS L3 Superior longitudinal fasciculus L | GCST90384565 | 1.69 |
| 2537 | Mean volume of bilateral amygdala | GCST90474992 | 1.69 |
| 2538 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T318 | ECGA000318 | 1.69 |
| 2539 | Gastroduodenal ulcer | FING00000565 | 1.69 |
| 2540 | Left hippocampal volume | GCST90267952 | 1.69 |
| 2541 | FGF5 levels | GCST90469226 | 1.68 |
| 2542 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T318 | ECGU000318 | 1.68 |
| 2543 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 1.68 |
| 2544 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T100 | ECGA000100 | 1.68 |
| 2545 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105 | ECGU000105 | 1.68 |
| 2546 | TXNDC5 levels | GCST90470991 | 1.68 |
| 2547 | EFEMP1 levels | GCST90469078 | 1.68 |
| 2548 | Chronic pancreatitis | GCST90018601 | 1.68 |
| 2549 | Serum phosphate levels | GCST90025948 | 1.68 |
| 2550 | IGFBP4 levels | GCST90469530 | 1.68 |
| 2551 | AK2 levels | GCST90468270 | 1.68 |
| 2552 | TFPI2 levels | GCST90470838 | 1.68 |
| 2553 | Female infertility, cervigal, vaginal, other or unspecified origin | FING00000538 | 1.68 |
| 2554 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392 | ECGA000392 | 1.68 |
| 2555 | CRTAC1 levels | GCST90468870 | 1.68 |
| 2556 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 1.67 |
| 2557 | PEPD levels | GCST90470209 | 1.67 |
| 2558 | PPP1R14D levels | GCST90470303 | 1.67 |
| 2559 | ITGAM levels | GCST90469638 | 1.67 |
| 2560 | Total cerebellar volume (excluding Crus I vermis) | GCST90020190 | 1.67 |
| 2561 | SKAP2/VSIR ratio | GCST90315849 | 1.67 |
| 2562 | FYN levels | GCST90243200 | 1.67 |
| 2563 | aparc-Desikan lh volume supramarginal | GCST90002798 | 1.67 |
| 2564 | Triglycerides | Blood biochemistry | UKBB00000861 | 1.67 |
| 2565 | Saturated fatty acids to total fatty acids percentage | GCST90502697 | 1.67 |
| 2566 | Separation of retinal layers (serosa) | FING00001292 | 1.67 |
| 2567 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20 | ECGU000020 | 1.67 |
| 2568 | TIMP1 levels | GCST90470869 | 1.67 |
| 2569 | ICD10 N97.8: Female infertility of other origin | GCST90454225 | 1.66 |
| 2570 | Lumbar disc prolapse | FING00000735 | 1.66 |
| 2571 | MMP10 levels | GCST90012050 | 1.66 |
| 2572 | EGF/MGLL ratio | GCST90314610 | 1.66 |
| 2573 | Mean bone marrow fat fraction of thoracic vertebrae 8-12 | GCST90652385 | 1.66 |
| 2574 | SUGT1 levels | GCST90470780 | 1.66 |
| 2575 | YTHDF3 levels | GCST90471091 | 1.66 |
| 2576 | Posterior thigh muscle volume | GCST90267353 | 1.66 |
| 2577 | NXF1 levels | GCST90242149 | 1.65 |
| 2578 | CD3 on Terminally Differentiated CD4+ T cell | GCST90001844 | 1.65 |
| 2579 | LGALS1 levels | GCST90469759 | 1.65 |
| 2580 | POLR2F levels | GCST90470283 | 1.65 |
| 2581 | Total protein levels | GCST90468105 | 1.65 |
| 2582 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 1.65 |
| 2583 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 1.65 |
| 2584 | Right-hemisphere visual network to pallidum white-matter structural connectivity | GCST90302784 | 1.64 |
| 2585 | CD69/SCARF1 ratio | GCST90313885 | 1.64 |
| 2586 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T309 | ECGA000309 | 1.64 |
| 2587 | DTI autoptx FA fmi tract | GCST90385123 | 1.64 |
| 2588 | Ascites (non malignant) (PheCode 572) | GCST90476090 | 1.64 |
| 2589 | Hip fracture | GCST90161240 | 1.64 |
| 2590 | Macular pucker | FING00000745 | 1.64 |
| 2591 | FADD levels | GCST90469180 | 1.64 |
| 2592 | CLMP levels | GCST90468783 | 1.64 |
| 2593 | Back pain | symptoms | UKBB00000084 | 1.64 |
| 2594 | Cholesteryl ester (16:2) levels | GCST90025238 | 1.64 |
| 2595 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 1.64 |
| 2596 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320569 | 1.64 |
| 2597 | MET/PTPRF ratio | GCST90315435 | 1.64 |
| 2598 | STK24 levels | GCST90470766 | 1.64 |
| 2599 | Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditions | UKBB00000510 | 1.64 |
| 2600 | Right-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302845 | 1.64 |
| 2601 | CD99 levels | GCST90468658 | 1.64 |
| 2602 | KITLG/PLTP ratio | GCST90315252 | 1.63 |
| 2603 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155 | ECGA000155 | 1.63 |
| 2604 | IDP T1 FAST ROIs L supracalc cortex | GCST90002543 | 1.63 |
| 2605 | Obstructive chronic bronchitis (PheCode 496.21) | GCST90476030 | 1.63 |
| 2606 | IL15RA levels | GCST90469555 | 1.63 |
| 2607 | Erysipelas | FING00000518 | 1.63 |
| 2608 | ROR1 levels | GCST90470492 | 1.63 |
| 2609 | ACVRL1/SCARB2 ratio | GCST90313157 | 1.63 |
| 2610 | MPIG6B/PDGFB ratio | GCST90315482 | 1.63 |
| 2611 | PPP1R14A levels | GCST90470302 | 1.63 |
| 2612 | COPD-related respiratory insufficiency | FING00000352 | 1.62 |
| 2613 | TIMM8A levels | GCST90470868 | 1.62 |
| 2614 | GCC1 levels | GCST90469315 | 1.62 |
| 2615 | aparc-pial lh area supramarginal | GCST90003171 | 1.62 |
| 2616 | Non-HDL cholesterol levels | GCST90239669 | 1.62 |
| 2617 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500397 | 1.62 |
| 2618 | ALDH1A1/CA2 ratio | GCST90313243 | 1.62 |
| 2619 | IDP dMRI ProbtrackX ISOVF unc r | GCST90004551 | 1.62 |
| 2620 | Total cholesterol response to statins (relative logarithmic difference) | GCST90455608 | 1.62 |
| 2621 | GDNF levels | GCST90274792 | 1.62 |
| 2622 | SPINK5 levels | GCST90470724 | 1.61 |
| 2623 | APRT/MIF ratio | GCST90313336 | 1.61 |
| 2624 | BTN2A1/LILRB4 ratio | GCST90313546 | 1.61 |
| 2625 | X-21829 levels | GCST90200585 | 1.61 |
| 2626 | aparc-pial rh area parsopercularis | GCST90003191 | 1.61 |
| 2627 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183 | ECGU000183 | 1.61 |
| 2628 | ATOX1/SNAP29 ratio | GCST90313374 | 1.61 |
| 2629 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475352 | 1.61 |
| 2630 | IDP dMRI ProbtrackX MD slf r | GCST90004241 | 1.60 |
| 2631 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11 | ECGA000011 | 1.60 |
| 2632 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483 | ECGU000483 | 1.60 |
| 2633 | DXO levels | GCST90469055 | 1.60 |
| 2634 | Breast cancer [female] | neoplasms | UKBB00000108 | 1.60 |
| 2635 | aparc-a2009s lh volume S-subparietal | GCST90002995 | 1.60 |
| 2636 | CFI levels | GCST90240782 | 1.60 |
| 2637 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T301 | ECGU000301 | 1.60 |
| 2638 | Body fat percentage | GCST007064 | 1.60 |
| 2639 | Placental weight (maternal genotype, adjusted for sex and gestational age) | GCST90275190 | 1.60 |
| 2640 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 1.60 |
| 2641 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 1.60 |
| 2642 | NAA80 levels | GCST90469990 | 1.59 |
| 2643 | HSPB1 levels | GCST90179317 | 1.59 |
| 2644 | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels | GCST90200065 | 1.59 |
| 2645 | HNRNPK levels | GCST90469469 | 1.59 |
| 2646 | Offspring birth weight | GCST005314 | 1.59 |
| 2647 | DTI autoptx L1 cst r tract | GCST90385148 | 1.58 |
| 2648 | CDC27 levels | GCST90468664 | 1.58 |
| 2649 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358 | ECGU000358 | 1.58 |
| 2650 | PPP1R2 levels | GCST90470304 | 1.58 |
| 2651 | COL6A3/NBL1 ratio | GCST90314176 | 1.58 |
| 2652 | IDP dMRI ProbtrackX MD atr r | GCST90004222 | 1.58 |
| 2653 | DBI levels | GCST90468949 | 1.58 |
| 2654 | Total lipids in large HDL (UKB data field 23559) | GCST90269656 | 1.58 |
| 2655 | CERT levels | GCST90468717 | 1.58 |
| 2656 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 1.58 |
| 2657 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320642 | 1.58 |
| 2658 | Degree of unsaturation | GCST90502233 | 1.58 |
| 2659 | ALPI levels | GCST90468285 | 1.58 |
| 2660 | PTGR1 levels | GCST90470370 | 1.57 |
| 2661 | Abnormal heart sounds (PheCode 396) | GCST90475916 | 1.57 |
| 2662 | RGMB/SMOC2 ratio | GCST90315770 | 1.57 |
| 2663 | CBLN4/RET ratio | GCST90313660 | 1.57 |
| 2664 | Phospholipid levels in large HDL | GCST90092852 | 1.57 |
| 2665 | CASP3 levels | GCST90468545 | 1.57 |
| 2666 | Biliary atresia | GCST90296484 | 1.57 |
| 2667 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68 | ECGA000068 | 1.57 |
| 2668 | Skin color (cheek, B value) | GCST90502779 | 1.57 |
| 2669 | X-12510--2-aminooctanoic acid levels | GCST90243748 | 1.57 |
| 2670 | TREML1 levels | GCST90470961 | 1.57 |
| 2671 | MGMT levels | GCST90469902 | 1.57 |
| 2672 | PAK4 levels | GCST90470150 | 1.57 |
| 2673 | Average diameter for VLDL particles (UKB data field 23431) | GCST90269528 | 1.57 |
| 2674 | Abscess of anal and rectal regions | FING00000005 | 1.57 |
| 2675 | Volume of left medial nucleus | GCST90474892 | 1.56 |
| 2676 | aparc-pial lh area lateraloccipital | GCST90003151 | 1.56 |
| 2677 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels | GCST90200060 | 1.56 |
| 2678 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383 | ECGU000383 | 1.56 |
| 2679 | Medication use (beta blocking agents) | GCST90018766 | 1.56 |
| 2680 | Retention of urine (PheCode 599.2) | GCST90476150 | 1.56 |
| 2681 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93 | ECGU000093 | 1.56 |
| 2682 | GFRA3/LAYN ratio | GCST90314926 | 1.56 |
| 2683 | High density lipoprotein cholesterol levels | GCST90278635 | 1.56 |
| 2684 | Low hand grip strength (60 years and older) (FNIH) | GCST90007529 | 1.56 |
| 2685 | NFE2 levels | GCST90470035 | 1.56 |
| 2686 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | GCST90275047 | 1.56 |
| 2687 | AKT3 levels | GCST90468278 | 1.56 |
| 2688 | GAL levels | GCST90469300 | 1.55 |
| 2689 | wg lh intensity-contrast insula | GCST90003826 | 1.55 |
| 2690 | CDH3/NECTIN4 ratio | GCST90313952 | 1.55 |
| 2691 | Treatment/medication code - lisinopril | Medications | UKBB00000850 | 1.55 |
| 2692 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36 | ECGA000036 | 1.55 |
| 2693 | ASAH2 levels | GCST90468374 | 1.55 |
| 2694 | IDP dMRI TBSS FA Retrolenticular part of internal capsule L | GCST90003898 | 1.55 |
| 2695 | Metabolic syndrome | GCST90444489 | 1.55 |
| 2696 | aparc-a2009s lh volume G-oc-temp-med-Lingual | GCST90002946 | 1.55 |
| 2697 | IDP dMRI TBSS FA Superior corona radiata L | GCST90003902 | 1.55 |
| 2698 | MB levels | GCST90469869 | 1.55 |
| 2699 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 1.55 |
| 2700 | Left-hemisphere default mode network to putamen white-matter structural connectivity | GCST90302769 | 1.55 |
| 2701 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis L | GCST90004366 | 1.54 |
| 2702 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86 | ECGA000086 | 1.54 |
| 2703 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186 | ECGU000186 | 1.54 |
| 2704 | CPQ levels | GCST90468846 | 1.54 |
| 2705 | IDP dMRI TBSS MD Superior longitudinal fasciculus R | GCST90004067 | 1.54 |
| 2706 | DTI autoptx MD str r tract | GCST90385244 | 1.54 |
| 2707 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 1.54 |
| 2708 | Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482) | GCST90269579 | 1.54 |
| 2709 | DEFB4A or DEFB4B levels | GCST90468984 | 1.54 |
| 2710 | IGFBP7 levels | GCST90469532 | 1.54 |
| 2711 | Placental weight (maternal genotype, adjusted for sex) | GCST90275198 | 1.54 |
| 2712 | CORO1A levels | GCST90468832 | 1.54 |
| 2713 | FTCD levels | GCST90469274 | 1.54 |
| 2714 | PDGFB/TIMP3 ratio | GCST90315631 | 1.54 |
| 2715 | Esophagitis, GERD and related diseases | digestive | UKBB00000208 | 1.54 |
| 2716 | PIBF1 levels | GCST90470231 | 1.54 |
| 2717 | CD99/MMP3 ratio | GCST90313928 | 1.53 |
| 2718 | Degree of unsaturation | GCST90502734 | 1.53 |
| 2719 | KRT8 levels | GCST90469720 | 1.53 |
| 2720 | Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454) | GCST90269551 | 1.53 |
| 2721 | ADAM22 levels | GCST90468218 | 1.53 |
| 2722 | Mean volume of bilateral amygdala | GCST90474901 | 1.53 |
| 2723 | T1 FreeSurfer DKT rh insula area | GCST90384317 | 1.53 |
| 2724 | MED18 levels | GCST90469880 | 1.53 |
| 2725 | DCN levels | GCST90468956 | 1.53 |
| 2726 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72 | ECGA000072 | 1.53 |
| 2727 | Breast cancer | GCST007236 | 1.53 |
| 2728 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T317 | ECGU000317 | 1.53 |
| 2729 | SIGLEC9 levels | GCST90470637 | 1.53 |
| 2730 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T52 | ECGU000052 | 1.53 |
| 2731 | O-sulfo-l-tyrosine levels | GCST90243623 | 1.52 |
| 2732 | Triglyceride to HDL cholesterol ratio | GCST90295950 | 1.52 |
| 2733 | CIAPIN1 levels | GCST90468753 | 1.52 |
| 2734 | aparc-a2009s lh volume G-postcentral | GCST90002952 | 1.52 |
| 2735 | ABL1/CC2D1A ratio | GCST90313148 | 1.52 |
| 2736 | Calculus of lower urinary tract (PheCode 594.2) | GCST90476146 | 1.52 |
| 2737 | CTSO levels | GCST90468915 | 1.52 |
| 2738 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae) | GCST90027668 | 1.52 |
| 2739 | BOLA2 or BOLA2B levels | GCST90468460 | 1.52 |
| 2740 | RABGAP1L levels | GCST90470416 | 1.52 |
| 2741 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502649 | 1.52 |
| 2742 | MSTN levels | GCST90469953 | 1.52 |
| 2743 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes) | GCST90027701 | 1.51 |
| 2744 | aseg lh intensity Caudate | GCST90003769 | 1.51 |
| 2745 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 1.51 |
| 2746 | CLEC1B/VSIR ratio | GCST90314106 | 1.51 |
| 2747 | AIDA levels | GCST90468265 | 1.51 |
| 2748 | Miserableness | Mental health | UKBB00000478 | 1.51 |
| 2749 | Volume of left anterior amygdaloid area | GCST90474871 | 1.51 |
| 2750 | IDP dMRI ProbtrackX ICVF ar l | GCST90004375 | 1.51 |
| 2751 | Excessive scarring | GCST90483368 | 1.51 |
| 2752 | Nontoxic multinodular goiter | endocrine/metabolic | UKBB00000528 | 1.51 |
| 2753 | aparc-a2009s lh thickness S-cingul-Marginalis | GCST90003648 | 1.51 |
| 2754 | PDGFA/SPARC ratio | GCST90315620 | 1.51 |
| 2755 | RABEP1 levels | GCST90470414 | 1.50 |
| 2756 | IDP dMRI ProbtrackX L2 cst l | GCST90004281 | 1.50 |
| 2757 | CCL22 levels | GCST90240490 | 1.50 |
| 2758 | Right-hemisphere visual network to caudate white-matter structural connectivity | GCST90302782 | 1.50 |
| 2759 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 1.50 |
| 2760 | Omega-6 fatty acids levels | GCST90499170 | 1.50 |
| 2761 | MYDGF levels | GCST90469972 | 1.50 |
| 2762 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 1.50 |
| 2763 | rfMRI connectivity (ICA100 edge 961) | GCST90005814 | 1.49 |
| 2764 | 21-hydroxypregnenolone disulfate levels | GCST90199849 | 1.49 |
| 2765 | aparc-a2009s lh volume G+S-subcentral | GCST90002928 | 1.49 |
| 2766 | IDP T1 FAST ROIs V cerebellum VIIIb | GCST90002582 | 1.49 |
| 2767 | IDP dMRI TBSS MD Superior corona radiata L | GCST90004052 | 1.49 |
| 2768 | CPPED1 levels | GCST90468845 | 1.49 |
| 2769 | SMPD1 levels | GCST90470684 | 1.49 |
| 2770 | CD69/TIA1 ratio | GCST90313888 | 1.49 |
| 2771 | CNST/PRKAR1A ratio | GCST90314161 | 1.49 |
| 2772 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497863 | 1.49 |
| 2773 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 1.48 |
| 2774 | RHOC/TBCC ratio | GCST90315775 | 1.48 |
| 2775 | IDP dMRI TBSS L1 Sagittal stratum R | GCST90004105 | 1.48 |
| 2776 | FYB1/PPP1R12A ratio | GCST90314913 | 1.48 |
| 2777 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 1.48 |
| 2778 | Cardiac pacemaker in situ (PheCode 426.91) | GCST90475960 | 1.48 |
| 2779 | ERP29 levels | GCST90469149 | 1.48 |
| 2780 | Loud music exposure frequency | Hearing | UKBB00000410 | 1.48 |
| 2781 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500856 | 1.48 |
| 2782 | Keratoconus | FING00000709 | 1.48 |
| 2783 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238 | ECGU000238 | 1.48 |
| 2784 | T1 CAT volume R TemporalFusiformCortexposteriordivision | GCST90384075 | 1.47 |
| 2785 | aparc-a2009s rh volume S-front-inf | GCST90003050 | 1.47 |
| 2786 | Mean bone marrow fat fraction of lumbar vertebrae 1-5 | GCST90652391 | 1.47 |
| 2787 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502160 | 1.47 |
| 2788 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389 | ECGA000389 | 1.47 |
| 2789 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 1.47 |
| 2790 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T320 | ECGA000320 | 1.47 |
| 2791 | wg rh intensity-contrast precuneus | GCST90003851 | 1.47 |
| 2792 | Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels | GCST90060298 | 1.47 |
| 2793 | Alkaline phosphatase | Blood biochemistry | UKBB00000027 | 1.47 |
| 2794 | Primary Raynaud’s phenomenon | GCST90271714 | 1.47 |
| 2795 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 1.46 |
| 2796 | Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256) | GCST90468166 | 1.46 |
| 2797 | TIA1 levels | GCST90470862 | 1.46 |
| 2798 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 1.46 |
| 2799 | CRTAM/TNFRSF9 ratio | GCST90314280 | 1.46 |
| 2800 | wg rh intensity-contrast isthmuscingulate | GCST90003836 | 1.46 |
| 2801 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T312 | ECGA000312 | 1.46 |
| 2802 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156 | ECGA000156 | 1.46 |
| 2803 | Operation code - bunion/hallus valgus surgery | Operations | UKBB00000551 | 1.46 |
| 2804 | BA-exvivo lh thickness MT | GCST90003524 | 1.46 |
| 2805 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 1.46 |
| 2806 | IDP dMRI TBSS L2 Posterior corona radiata L | GCST90004150 | 1.46 |
| 2807 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 1.45 |
| 2808 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48 | ECGA000048 | 1.45 |
| 2809 | IDP dMRI TBSS OD Posterior corona radiata R | GCST90004428 | 1.45 |
| 2810 | Succinoyltaurine levels | GCST90200235 | 1.45 |
| 2811 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320628 | 1.45 |
| 2812 | ADGRE2 levels | GCST90468237 | 1.45 |
| 2813 | IDP dMRI TBSS L3 Superior longitudinal fasciculus R | GCST90004211 | 1.45 |
| 2814 | Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels | GCST90060420 | 1.45 |
| 2815 | Average diameter for HDL particles | GCST90092828 | 1.45 |
| 2816 | RBM17 levels | GCST90470434 | 1.45 |
| 2817 | FCRL6/GZMA ratio | GCST90314806 | 1.45 |
| 2818 | IDP T1 FAST ROIs R cerebellum V | GCST90002565 | 1.45 |
| 2819 | ADGRE5/VCAM1 ratio | GCST90313184 | 1.45 |
| 2820 | SWAP70 levels | GCST90242931 | 1.45 |
| 2821 | Biological Father: Coronary Artery / Coronary Heart Disease | GCST90475241 | 1.45 |
| 2822 | MITD1/SNX9 ratio | GCST90315454 | 1.44 |
| 2823 | TOMM20 levels | GCST90470931 | 1.44 |
| 2824 | Left-hemisphere salience/ventral attention network to right-hemisphere control network white-matter structural connectivity | GCST90302717 | 1.44 |
| 2825 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 1.44 |
| 2826 | rfMRI connectivity ICA-features 2 | GCST90006340 | 1.44 |
| 2827 | Other septicaemia | FING00001097 | 1.44 |
| 2828 | MMP3 levels | GCST90469920 | 1.44 |
| 2829 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T97 | ECGU000097 | 1.44 |
| 2830 | NAAA levels | GCST90469991 | 1.44 |
| 2831 | aparc-a2009s lh area G-pariet-inf-Supramar | GCST90003322 | 1.44 |
| 2832 | ARHGAP25 levels | GCST90242651 | 1.44 |
| 2833 | FUT3 or FUT5 levels | GCST90469280 | 1.44 |
| 2834 | EGF levels | GCST90469086 | 1.44 |
| 2835 | IRAK4 levels | GCST90469628 | 1.44 |
| 2836 | IDP T1 FAST ROIs R parietal operc cortex | GCST90002536 | 1.44 |
| 2837 | CXCL17/SFTPA2 ratio | GCST90314341 | 1.44 |
| 2838 | COL9A1 levels | GCST90468822 | 1.44 |
| 2839 | Whole body fat-free mass | Impedance measures | UKBB00000915 | 1.44 |
| 2840 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 1.44 |
| 2841 | IDP dMRI TBSS MD Sagittal stratum R | GCST90004057 | 1.44 |
| 2842 | FUT3 levels | GCST90241216 | 1.43 |
| 2843 | ALOX15B levels | GCST90617547 | 1.43 |
| 2844 | IDP dMRI ProbtrackX ICVF ilf l | GCST90004389 | 1.43 |
| 2845 | 1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels | GCST90200330 | 1.43 |
| 2846 | MMP8/PGLYRP1 ratio | GCST90315465 | 1.43 |
| 2847 | Congenital lactase deficiency | FING00000329 | 1.43 |
| 2848 | Suicide or other Intentional self-harm | FING00001345 | 1.43 |
| 2849 | CTHRC1 levels | GCST90468902 | 1.43 |
| 2850 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 1.43 |
| 2851 | F3 levels | GCST90012014 | 1.43 |
| 2852 | FURIN/INHBC ratio | GCST90314886 | 1.43 |
| 2853 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320938 | 1.43 |
| 2854 | Cholesterol in Small LDL | GCST90499559 | 1.43 |
| 2855 | Trigger finger | GCST90104907 | 1.43 |
| 2856 | PAXX levels | GCST90470161 | 1.43 |
| 2857 | Other abnormal uterine and vaginal bleeding | FING00000919 | 1.42 |
| 2858 | Takes medication for high blood pressure? | GCST90475216 | 1.42 |
| 2859 | Illnesses of father - Lung cancer | Family history | UKBB00000344 | 1.42 |
| 2860 | Cystitis | FING00000376 | 1.42 |
| 2861 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95) | GCST90320658 | 1.42 |
| 2862 | DKK1 levels | GCST90012060 | 1.42 |
| 2863 | GRAP2 levels | GCST90469399 | 1.42 |
| 2864 | Whole body water mass | Impedance measures | UKBB00000916 | 1.42 |
| 2865 | LY6D/NECTIN4 ratio | GCST90315344 | 1.42 |
| 2866 | BA-exvivo rh thickness V1 | GCST90003536 | 1.42 |
| 2867 | Principal component-derived dietary pattern 14 | GCST90133019 | 1.42 |
| 2868 | CLEC1B levels | GCST90468768 | 1.42 |
| 2869 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217 | ECGU000217 | 1.41 |
| 2870 | Bone marrow fat fraction of thoracic vertebra 11 | GCST90652383 | 1.41 |
| 2871 | TBC1D23 levels | GCST90470810 | 1.41 |
| 2872 | 5alpha-pregnan-3beta,20alpha-diol disulfate levels | GCST90199838 | 1.41 |
| 2873 | Triacylglycerol (54:2) [NL-18:0] levels | GCST90025175 | 1.41 |
| 2874 | Androstenediol (3alpha, 17alpha) monosulfate (3) levels | GCST90199856 | 1.41 |
| 2875 | GTPBP2 levels | GCST90469417 | 1.41 |
| 2876 | AP1G2 levels | GCST90468323 | 1.41 |
| 2877 | CELA3A/CPB1 ratio | GCST90314010 | 1.41 |
| 2878 | ASRGL1 levels | GCST90468379 | 1.40 |
| 2879 | TNFRSF14/TNFRSF1A ratio | GCST90315935 | 1.40 |
| 2880 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251 | ECGU000251 | 1.40 |
| 2881 | Triacylglycerol_51:4_[M+NH4]1+ levels | GCST90060491 | 1.40 |
| 2882 | CASP8/RILP ratio | GCST90313657 | 1.40 |
| 2883 | DTI autoptx FA ilf r tract | GCST90385127 | 1.40 |
| 2884 | RGS10 levels | GCST90470465 | 1.40 |
| 2885 | FCGR3B levels | GCST90469202 | 1.40 |
| 2886 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T237 | ECGU000237 | 1.40 |
| 2887 | Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486) | GCST90269583 | 1.40 |
| 2888 | CLEC1A/GPR37 ratio | GCST90314084 | 1.40 |
| 2889 | Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney disease | GCST90265175 | 1.40 |
| 2890 | Benign neoplasm: Colon | FING00000171 | 1.40 |
| 2891 | Ulcerative colitis | GCST90468152 | 1.40 |
| 2892 | NTF3 levels | GCST90470094 | 1.40 |
| 2893 | IDP dMRI ProbtrackX L3 slf r | GCST90004322 | 1.40 |
| 2894 | Liver enzyme levels (alkaline phosphatase) | GCST90013406 | 1.40 |
| 2895 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 1.40 |
| 2896 | Other forms of systemic lupus erythematosus | FING00001051 | 1.40 |
| 2897 | DTI autoptx L3 unc r tract | GCST90385219 | 1.40 |
| 2898 | aparc-a2009s rh area G-cingul-Post-ventral | GCST90003380 | 1.39 |
| 2899 | FCN1 levels | GCST90618565 | 1.39 |
| 2900 | RAB27B levels | GCST90470405 | 1.39 |
| 2901 | Average diameter for HDL particles (UKB data field 23433) | GCST90269530 | 1.39 |
| 2902 | CD55/ITGB1 ratio | GCST90313846 | 1.39 |
| 2903 | IDP dMRI ProbtrackX L1 atr l | GCST90004248 | 1.39 |
| 2904 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384 | ECGU000384 | 1.39 |
| 2905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96 | ECGU000096 | 1.38 |
| 2906 | IDP dMRI TBSS L1 Superior corona radiata R | GCST90004099 | 1.38 |
| 2907 | ARHGAP1 levels | GCST90468352 | 1.38 |
| 2908 | RNF41 levels | GCST90470485 | 1.38 |
| 2909 | PTN levels | GCST90470374 | 1.38 |
| 2910 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497763 | 1.38 |
| 2911 | aseg rh volume Caudate | GCST90002638 | 1.38 |
| 2912 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500569 | 1.38 |
| 2913 | CD69/SNAP23 ratio | GCST90313886 | 1.38 |
| 2914 | DUT levels | GCST90469054 | 1.38 |
| 2915 | Cholesterol levels in very small VLDL | GCST90500712 | 1.38 |
| 2916 | Alkaline phosphatase (UKB data field 30610) | GCST90468060 | 1.38 |
| 2917 | FKBP14 levels | GCST90469241 | 1.37 |
| 2918 | Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels | GCST90060261 | 1.37 |
| 2919 | TMSB10 levels | GCST90470894 | 1.37 |
| 2920 | TNFSF11 levels | GCST90470918 | 1.37 |
| 2921 | CMIP levels | GCST90468795 | 1.37 |
| 2922 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8) | GCST90320827 | 1.37 |
| 2923 | Volume of left paralaminar nucleus | GCST90474895 | 1.37 |
| 2924 | IGFBP6/MFAP5 ratio | GCST90315135 | 1.37 |
| 2925 | NID1/TIMP3 ratio | GCST90315543 | 1.37 |
| 2926 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385 | ECGU000385 | 1.36 |
| 2927 | Total lipids in very large VLDL | GCST90500607 | 1.36 |
| 2928 | CFB levels | GCST90468723 | 1.36 |
| 2929 | Non-cancer illness code, self-reported - osteoarthritis | Medical conditions | UKBB00000521 | 1.36 |
| 2930 | HLA-E levels | GCST90469459 | 1.36 |
| 2931 | PDLIM5 levels | GCST90470197 | 1.36 |
| 2932 | Average diameter for VLDL particles | GCST90500279 | 1.36 |
| 2933 | NEXN levels | GCST90470030 | 1.36 |
| 2934 | Concentration of very large VLDL particles | GCST90500628 | 1.36 |
| 2935 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T314 | ECGA000314 | 1.36 |
| 2936 | MANF levels | GCST90469846 | 1.36 |
| 2937 | PRDX3 levels | GCST90470317 | 1.35 |
| 2938 | aparc-Desikan lh thickness lateraloccipital | GCST90003455 | 1.35 |
| 2939 | Bone marrow fat fraction of thoracic vertebra 9 | GCST90652381 | 1.35 |
| 2940 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475356 | 1.35 |
| 2941 | PRKRA levels | GCST90470331 | 1.35 |
| 2942 | Abdominal subcutaneous adipose tissue | GCST90267347 | 1.35 |
| 2943 | EVI5 levels | GCST90469158 | 1.35 |
| 2944 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497730 | 1.35 |
| 2945 | MOCS2 levels | GCST90469928 | 1.35 |
| 2946 | Visceral adipose tissue | GCST90267357 | 1.35 |
| 2947 | T1 FreeSurfer BA lh V2 exvivo thickness | GCST90385529 | 1.35 |
| 2948 | NOTCH1 levels | GCST90470065 | 1.35 |
| 2949 | IDP dMRI TBSS L2 Anterior corona radiata R | GCST90004145 | 1.35 |
| 2950 | IL18R1 levels | GCST90241607 | 1.35 |
| 2951 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126 | ECGA000126 | 1.35 |
| 2952 | Atopic dermatitis | GCST90018564 | 1.35 |
| 2953 | PILRB levels | GCST90470237 | 1.35 |
| 2954 | Diastolic blood pressure (BMI unadjusted) | GCST90335164 | 1.35 |
| 2955 | Triglycerides x low social support interaction (2df test) | GCST90570681 | 1.35 |
| 2956 | EPO/TFRC ratio | GCST90314684 | 1.35 |
| 2957 | BID levels | GCST90468444 | 1.35 |
| 2958 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326 | ECGA000326 | 1.35 |
| 2959 | Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels | GCST90060307 | 1.35 |
| 2960 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T357 | ECGU000357 | 1.34 |
| 2961 | aparc-Desikan rh volume cuneus | GCST90002805 | 1.34 |
| 2962 | MSRA/SNAP29 ratio | GCST90315500 | 1.34 |
| 2963 | aparc-a2009s lh area S-oc-middle+Lunatus | GCST90003353 | 1.34 |
| 2964 | DCTD levels | GCST90468957 | 1.34 |
| 2965 | P4HB levels | GCST90470140 | 1.34 |
| 2966 | Glutamine levels | GCST90092818 | 1.34 |
| 2967 | S100A16 levels | GCST90470516 | 1.34 |
| 2968 | DTI TBSS MD Anterior corona radiata R | GCST90384594 | 1.34 |
| 2969 | IDP dMRI ProbtrackX FA ar l | GCST90003925 | 1.34 |
| 2970 | Volume of right paralaminar nucleus | GCST90475048 | 1.34 |
| 2971 | Right ventricular end systolic volume | GCST90134589 | 1.34 |
| 2972 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 1.34 |
| 2973 | CDKN1A levels | GCST90468684 | 1.34 |
| 2974 | Breast cancer (PheCode 174) | GCST90435600 | 1.34 |
| 2975 | APRT/PSME1 ratio | GCST90313338 | 1.34 |
| 2976 | IDP dMRI TBSS MD Uncinate fasciculus L | GCST90004072 | 1.33 |
| 2977 | Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers) | FING00000751 | 1.33 |
| 2978 | BCL2L2 levels | GCST90422077 | 1.33 |
| 2979 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66 | ECGU000066 | 1.33 |
| 2980 | aseg global volume BrainSegNotVentSurf | GCST90002592 | 1.33 |
| 2981 | AZU1/MPO ratio | GCST90313425 | 1.33 |
| 2982 | Diffuse idiopathic skeletal hyperostosis flow score | GCST90134532 | 1.33 |
| 2983 | IDP dMRI TBSS ICVF Sagittal stratum L | GCST90004358 | 1.33 |
| 2984 | CRKL/FIS1 ratio | GCST90314266 | 1.33 |
| 2985 | Triacylglycerol_50:5_[M+NH4]1+ levels | GCST90060463 | 1.33 |
| 2986 | Plasma N-acetyltaurine levels in chronic kidney disease | GCST90265600 | 1.33 |
| 2987 | Carboplatin drug response (IC50) | GCST90011783 | 1.33 |
| 2988 | IDP dMRI ProbtrackX MD ptr r | GCST90004239 | 1.33 |
| 2989 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 100) | GCST90320919 | 1.33 |
| 2990 | SRP14 levels | GCST90470742 | 1.33 |
| 2991 | BAG3 levels | GCST90468416 | 1.33 |
| 2992 | DCTN1/ERBIN ratio | GCST90314429 | 1.32 |
| 2993 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 1.32 |
| 2994 | STAB2 levels | GCST90470755 | 1.32 |
| 2995 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240 | ECGA000240 | 1.32 |
| 2996 | CLEC14A/EPHB4 ratio | GCST90314079 | 1.32 |
| 2997 | aparc-Desikan lh area supramarginal | GCST90003103 | 1.32 |
| 2998 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500655 | 1.32 |
| 2999 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226 | ECGU000226 | 1.32 |
| 3000 | RWDD1/SUMF2 ratio | GCST90315795 | 1.32 |